Patient Selection for Hypoxia Modifying Treatments in Larynx Carcinomas
Patient Selection for Hypoxia Modifying Treatments Based on Functional Microregional Imaging of Tumor Vasculature, Oxygenation and Proliferation in Squamous Cell Carcinoma of the Larynx
Sponsor: Dutch Cancer Society
This observational or N/A phase trial investigates Larynx Cancer and is currently completed. Dutch Cancer Society leads this study, which shows 11 recorded versions since 2001 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2022 — Jul 2024 [monthly]
Completed
-
Dec 2021 — Mar 2022 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: PHASE3 → None
-
Aug 2017 — Apr 2018 [monthly]
Completed PHASE3
-
Jan 2017 — Aug 2017 [monthly]
Completed PHASE3
First recorded
Jul 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dutch Cancer Society
- Radboud University Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Amsterdam, Netherlands
- • Arnhem, Netherlands
- • Maastricht, Netherlands
- • Nijmegen, Netherlands
- • Utrecht, Netherlands